BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
NCT02505516 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2015-07-22
Summary
patients om metformin from diabetic clinic were checked for bladder cancer
Conditions
Interventions
- OTHER
-
metformin
Sponsors & Collaborators
-
UFUOMA MILLER FAKPOR
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 25 Years
- Max Age
- 86 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2014-01-31
- Completion
- 2014-02-28
Countries
- Ghana
Study Locations
More Related Trials
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.
NCT06289270 ·Status: RECRUITING
-
Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?
NCT05167916 ·Status: UNKNOWN ·Phase: NA
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
Skipping BCG for T1a Urinary Bladder Tumor.
NCT04298073 ·Status: UNKNOWN
-
Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
NCT00539773 ·Status: COMPLETED ·Phase: NA
-
The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
NCT01968928 ·Status: UNKNOWN
-
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
NCT02311101 ·Status: COMPLETED ·Phase: PHASE1
-
Bladder Bank (a Prospective Banking Study)
NCT06109857 ·Status: RECRUITING
-
Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
NCT03658304 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
NCT06255964 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Outcome of Treating Bladder Cancer in Sohag University Hospital
NCT05082818 ·Status: COMPLETED
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
NCT00191711 ·Status: COMPLETED ·Phase: PHASE2
-
Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy
NCT04256122 ·Status: UNKNOWN
-
Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
NCT06870253 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer
NCT04319263 ·Status: COMPLETED ·Phase: NA
-
An Educational Intervention for Patients With Bladder Cancer
NCT01915121 ·Status: COMPLETED ·Phase: NA
-
Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer
NCT04525781 ·Status: UNKNOWN
-
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
NCT06193941 ·Status: COMPLETED
-
Sequential Combination Therapy in Bladder Cancer
NCT03790384 ·Status: UNKNOWN ·Phase: PHASE4
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population
NCT05070039 ·Status: COMPLETED ·Phase: NA
-
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
NCT03558503 ·Status: COMPLETED ·Phase: PHASE2